Skip to main content
Top
Published in: European Journal of Nutrition 2/2014

01-03-2014 | Original Contribution

Fructooligosaccharide augments benefits of quercetin-3-O-β-glucoside on insulin sensitivity and plasma total cholesterol with promotion of flavonoid absorption in sucrose-fed rats

Authors: Panchita Phuwamongkolwiwat, Takuya Suzuki, Tohru Hira, Hiroshi Hara

Published in: European Journal of Nutrition | Issue 2/2014

Login to get access

Abstract

Purpose

The aim was to investigate both individual and synergistic effects of quercetin-3-O-β-glucoside (Q3G) and fructooligosaccharide (FOS) on indices of metabolic syndrome and plasma total cholesterol level with potential mechanisms of action.

Methods

Five groups of rats were fed a dextrin-based diet as the normal reference group, or sucrose-based (S) diets with 0.3 % Q3G, 5 % FOS, or 0.3 % Q3G + 5 % FOS (Q3G + FOS) for 48 days. Oral glucose tolerance tests (OGTTs) were conducted on days 0, 14, 28, and 45, and adipose tissue and aortic blood were collected on day 48. Effects of Q3G and FOS on portal GLP-1 secretion were separately examined using rats after ileal administration.

Results

Abdominal fat weight reduced in FOS-fed groups. Blood glucose levels of the Q3G + FOS group at 60 min in OGTT and HOMA-IR (0.25 ± 0.03 vs 0.83 ± 0.12 on day 45) were clearly lower in the Q3G + FOS group than in S group throughout the experimental period. Muscle Akt phosphorylation was enhanced only in the Q3G group. The plasma quercetin was largely increased by FOS feeding on day 48 (18.37 ± 1.20 with FOS, 2.02 ± 0.30 without FOS). Plasma total cholesterol levels in the Q3G + FOS group (3.10 ± 0.12, P < 0.05 on day 45) were clearly suppressed compared to the S group (4.03 ± 0.18). GLP-1 secretion was enhanced in Q3G + FOS group than in Q3G or FOS group.

Conclusion

Q3G + FOS diet improved glucose tolerance, insulin sensitivity, and total cholesterol level with increasing GLP-1 secretion and a higher level of blood quercetin. Q3G + FOS may reduce the risk of T2DM.
Literature
1.
go back to reference Agriculture USDo, Health USDo, Services H (2000) Nutrition and your health: dietary guidelines for Americans. US Dept. of Agriculture Agriculture USDo, Health USDo, Services H (2000) Nutrition and your health: dietary guidelines for Americans. US Dept. of Agriculture
3.
go back to reference Campos D, Betalleluz-Pallardel I, Chirinos R, Aguilar-Galvez A, Noratto G, Pedreschi R (2012) Prebiotic effects of yacon (Smallanthus sonchifolius Poepp. & Endl), a source of fructooligosaccharides and phenolic compounds with antioxidant activity. Food Chem 135:1592–1599. doi:10.1016/j.foodchem.2012.05.088 CrossRef Campos D, Betalleluz-Pallardel I, Chirinos R, Aguilar-Galvez A, Noratto G, Pedreschi R (2012) Prebiotic effects of yacon (Smallanthus sonchifolius Poepp. & Endl), a source of fructooligosaccharides and phenolic compounds with antioxidant activity. Food Chem 135:1592–1599. doi:10.​1016/​j.​foodchem.​2012.​05.​088 CrossRef
4.
go back to reference Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM (2005) Involvement of endogenous glucagon-like peptide-1(7–36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 185:457–465. doi:10.1677/joe.1.06100 CrossRef Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM (2005) Involvement of endogenous glucagon-like peptide-1(7–36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 185:457–465. doi:10.​1677/​joe.​1.​06100 CrossRef
5.
go back to reference Cani PD, Neyrinck AM, Maton N, Delzenne NM (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 13:1000–1007. doi:10.1038/oby.2005.117 CrossRef Cani PD, Neyrinck AM, Maton N, Delzenne NM (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 13:1000–1007. doi:10.​1038/​oby.​2005.​117 CrossRef
6.
go back to reference Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728–1731. doi:10.1126/science.292.5522.1728 CrossRef Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728–1731. doi:10.​1126/​science.​292.​5522.​1728 CrossRef
7.
go back to reference Costa GT, Guimarães SB, Sampaio HADC (2012) Fructo-oligosaccharide effects on blood glucose: an overview. Acta Cirurgica Brasileira 27:279–282CrossRef Costa GT, Guimarães SB, Sampaio HADC (2012) Fructo-oligosaccharide effects on blood glucose: an overview. Acta Cirurgica Brasileira 27:279–282CrossRef
8.
go back to reference Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM (2000) Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr 130:1314–1319 Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM (2000) Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr 130:1314–1319
9.
go back to reference Delzenne NM, Cani PD (2005) A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 8:636–640CrossRef Delzenne NM, Cani PD (2005) A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 8:636–640CrossRef
10.
go back to reference Elson DF, Meredith M (1998) Therapy for type 2 diabetes mellitus. WMJ 97:49–54 Elson DF, Meredith M (1998) Therapy for type 2 diabetes mellitus. WMJ 97:49–54
11.
go back to reference Formica JV, Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33:1061–1080CrossRef Formica JV, Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33:1061–1080CrossRef
12.
go back to reference Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. J Clin Invest 112:197–208CrossRef Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. J Clin Invest 112:197–208CrossRef
13.
go back to reference Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, DeFronzo RA, Ferrannini E (2002) Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 87:5098–5103CrossRef Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, DeFronzo RA, Ferrannini E (2002) Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 87:5098–5103CrossRef
14.
go back to reference Goto T, Lee J-Y, Teraminami A, Kim Y-I, Hirai S, Uemura T, Inoue H, Takahashi N, Kawada T (2011) Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res 52:873–884. doi:10.1194/jlr.M011320 CrossRef Goto T, Lee J-Y, Teraminami A, Kim Y-I, Hirai S, Uemura T, Inoue H, Takahashi N, Kawada T (2011) Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res 52:873–884. doi:10.​1194/​jlr.​M011320 CrossRef
15.
go back to reference Grundy SM (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92:399–404CrossRef Grundy SM (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92:399–404CrossRef
16.
17.
go back to reference Jung CH, Cho I, Ahn J, Jeon T-I, Ha T-Y (2013) Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res 27:139–143. doi:10.1002/ptr.4687 CrossRef Jung CH, Cho I, Ahn J, Jeon T-I, Ha T-Y (2013) Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res 27:139–143. doi:10.​1002/​ptr.​4687 CrossRef
18.
go back to reference Juśkiewicz J, Milala J, Jurgoński A, Król B, Zduńczyk Z (2011) Consumption of polyphenol concentrate with dietary fructo-oligosaccharides enhances cecal metabolism of quercetin glycosides in rats. Nutrition 27:351–357. doi:10.1016/j.nut.2010.02.002 CrossRef Juśkiewicz J, Milala J, Jurgoński A, Król B, Zduńczyk Z (2011) Consumption of polyphenol concentrate with dietary fructo-oligosaccharides enhances cecal metabolism of quercetin glycosides in rats. Nutrition 27:351–357. doi:10.​1016/​j.​nut.​2010.​02.​002 CrossRef
19.
go back to reference Kergoat M, Bailbe D, Portha B (1987) Effect of high sucrose diet on insulin secretion and insulin action: a study in the normal rat. Diabetologia 30:252–258CrossRef Kergoat M, Bailbe D, Portha B (1987) Effect of high sucrose diet on insulin secretion and insulin action: a study in the normal rat. Diabetologia 30:252–258CrossRef
22.
go back to reference Kobori M, Masumoto S, Akimoto Y, Oike H (2011) Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6 J mice. Mol Nutr Food Res 55:530–540CrossRef Kobori M, Masumoto S, Akimoto Y, Oike H (2011) Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6 J mice. Mol Nutr Food Res 55:530–540CrossRef
23.
go back to reference Le Marchand-Brustel Y, Gautier N, Cormont M, Van Obberghen E (1995) Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. Endocrinology 136:3564–3570. doi:10.1210/en.136.8.3564 Le Marchand-Brustel Y, Gautier N, Cormont M, Van Obberghen E (1995) Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. Endocrinology 136:3564–3570. doi:10.​1210/​en.​136.​8.​3564
24.
go back to reference Lund S, Holman GD, Schmitz O, Pedersen O (1995) Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92:5817–5821CrossRef Lund S, Holman GD, Schmitz O, Pedersen O (1995) Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92:5817–5821CrossRef
25.
go back to reference Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426:331–336CrossRef Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426:331–336CrossRef
26.
go back to reference Marlett JA, McBurney MI, Slavin JL, Association AD (2002) Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 102:993–1000CrossRef Marlett JA, McBurney MI, Slavin JL, Association AD (2002) Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 102:993–1000CrossRef
27.
go back to reference Mathern JR, Raatz SK, Thomas W, Slavin JL (2009) Effect of fenugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects. Phytother Res 23:1543–1548. doi:10.1002/ptr.2795 CrossRef Mathern JR, Raatz SK, Thomas W, Slavin JL (2009) Effect of fenugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects. Phytother Res 23:1543–1548. doi:10.​1002/​ptr.​2795 CrossRef
28.
go back to reference Matsukawa N, Matsumoto M, Shinoki A, Hagio M, Inoue R, Hara H (2009) Nondigestible saccharides suppress the bacterial degradation of quercetin aglycone in the large intestine and enhance the bioavailability of quercetin glucoside in rats. J Agric Food Chem 57:9462–9468. doi:10.1021/jf9024079 CrossRef Matsukawa N, Matsumoto M, Shinoki A, Hagio M, Inoue R, Hara H (2009) Nondigestible saccharides suppress the bacterial degradation of quercetin aglycone in the large intestine and enhance the bioavailability of quercetin glucoside in rats. J Agric Food Chem 57:9462–9468. doi:10.​1021/​jf9024079 CrossRef
29.
go back to reference Nakamura Y, Natsume M, Yasuda A, Ishizaka M, Kawahata K, Koga J (2011) Fructooligosaccharides suppress high-fat diet-induced fat accumulation in C57BL/6 J mice. BioFactors. doi:10.1002/biof.147 Nakamura Y, Natsume M, Yasuda A, Ishizaka M, Kawahata K, Koga J (2011) Fructooligosaccharides suppress high-fat diet-induced fat accumulation in C57BL/6 J mice. BioFactors. doi:10.​1002/​biof.​147
30.
go back to reference Nazare JA, Sauvinet V, Normand S, Guerin-Deremaux L, Gabert L, Desage M, Wils D, Laville M (2011) Impact of a resistant dextrin with a prolonged oxidation pattern on day-long ghrelin profile. J Am Coll Nutr 30:63–72CrossRef Nazare JA, Sauvinet V, Normand S, Guerin-Deremaux L, Gabert L, Desage M, Wils D, Laville M (2011) Impact of a resistant dextrin with a prolonged oxidation pattern on day-long ghrelin profile. J Am Coll Nutr 30:63–72CrossRef
31.
go back to reference Organization WH (2003) Diet, nutrition and the prevention of chronic disease. World Health Organization, Geneva Organization WH (2003) Diet, nutrition and the prevention of chronic disease. World Health Organization, Geneva
33.
go back to reference Reeves PG, Nielsen FH, Fahey GC (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951 Reeves PG, Nielsen FH, Fahey GC (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951
34.
go back to reference Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M (2008) Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16:2081–2087. doi:10.1038/oby.2008.315 CrossRef Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M (2008) Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16:2081–2087. doi:10.​1038/​oby.​2008.​315 CrossRef
36.
37.
go back to reference Seidell JC (2000) Obesity, insulin resistance and diabetes—a worldwide epidemic. Br J Nutr 83(Suppl 1):S5–S8 Seidell JC (2000) Obesity, insulin resistance and diabetes—a worldwide epidemic. Br J Nutr 83(Suppl 1):S5–S8
38.
go back to reference Shinoki A, Hara H (2011) Dietary fructo-oligosaccharides improve insulin sensitivity along with the suppression of adipocytokine secretion from mesenteric fat cells in rats. Br J Nutr 106:1190–1197. doi:10.1017/S000711451100167X CrossRef Shinoki A, Hara H (2011) Dietary fructo-oligosaccharides improve insulin sensitivity along with the suppression of adipocytokine secretion from mesenteric fat cells in rats. Br J Nutr 106:1190–1197. doi:10.​1017/​S000711451100167​X CrossRef
39.
go back to reference Soria A, D’Alessandro ME, Lombardo YB (2001) Duration of feeding on a sucrose-rich diet determines metabolic and morphological changes in rat adipocytes. J Appl Physiol 91:2109–2116 Soria A, D’Alessandro ME, Lombardo YB (2001) Duration of feeding on a sucrose-rich diet determines metabolic and morphological changes in rat adipocytes. J Appl Physiol 91:2109–2116
40.
go back to reference Suzuki T, Hara H (2004) Ingestion of guar gum hydrolysate, a soluble and fermentable nondigestible saccharide, improves glucose intolerance and prevents hypertriglyceridemia in rats fed fructose. J Nutr 134:1942–1947 Suzuki T, Hara H (2004) Ingestion of guar gum hydrolysate, a soluble and fermentable nondigestible saccharide, improves glucose intolerance and prevents hypertriglyceridemia in rats fed fructose. J Nutr 134:1942–1947
42.
go back to reference Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, Christopoulos A, Sexton PM (2011) Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. J Pharmacol Exp Ther 336:540–550. doi:10.1124/jpet.110.176362 CrossRef Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, Christopoulos A, Sexton PM (2011) Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. J Pharmacol Exp Ther 336:540–550. doi:10.​1124/​jpet.​110.​176362 CrossRef
Metadata
Title
Fructooligosaccharide augments benefits of quercetin-3-O-β-glucoside on insulin sensitivity and plasma total cholesterol with promotion of flavonoid absorption in sucrose-fed rats
Authors
Panchita Phuwamongkolwiwat
Takuya Suzuki
Tohru Hira
Hiroshi Hara
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2014
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-013-0546-2

Other articles of this Issue 2/2014

European Journal of Nutrition 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.